1|Page
NR 567 FINAL EXAM LATEST 2025/2026 ACTUAL EXAM WITH
COMPLETE QUESTIONS AND CORRECT DETAILED ANSWERS (100%
VERIFIED ANSWERS) |ALREADY GRADED A+| ||PROFESSOR
VERIFIED|| ||BRANDNEW!!!||
your patient presents with essential hypertension, and in
reviewing lab results, you note that the circulating plasma renin
and catecholamine levels are high. you decide to lower blood
pressure by reducing both cardiac output and systemic vascular
resistance (blocking both alpha and beta-adrenergic receptors)
with a single pharmaceutical agent. which of the following is most
likely to achieve this goal? - ANSWER-labetalol (trandate)
a nonselective beta-blocker was initiated for your patient. which of
the following diagnoses warrants initiating this pharmaceutical
agent? - ANSWER-- asthma
- bradycardia
- severe left ventricular HF
- hyperthyroid crisis ****
you are managing a patient with a history of coronary artery
disease and transient ischemic attacks. low-dose aspirin
,2|Page
treatment is considered, but the patient has a reported history of
aspirin allergy. which of the following is the best alternative? -
ANSWER-- dipyridamole (persantine)
- clopidogrel (plavix) ****
- acetaminophen (tylenol)
- ketorolac (toradol)
which of the following adverse effects is likely when an
angiotensin-converting enzyme inhibitor (ACEI) is used with
spironolactone therapy? - ANSWER-hypotension
hyperkalemia ***
renal insufficiency
proteinuria
all of the following are beneficial effects of beta-blocker therapy
for use in patients with cirrhosis except ________. - ANSWER--
diminished portal hypertension
- increased CO ****
- decreased incidence of esophageal bleeding
-decreased mortality rate
, 3|Page
reducing cardiovascular events in patients with moderate to
severe uncomplicated hypertension is an important consideration
when choosing initial therapy. Which of the following is not
recommended as a first-line treatment to reduce cardiovascular
events? - ANSWER-- angiotensin-converting enzyme inhibitors
(ACEI)
- angiotensin receptor blockers (ARBS)
- beta agonist receptor blockers ****
- dihydropyridine calcium channel blockers (CCB)
which medication class would be most advantageous to use in
treating a patient with hypertension and symptomatic benign
prostatic hyperplasia (BPH) - ANSWER-- thiazide diuretic
- calcium channel blocker
- angiotensin-converting enzyme inhibitor
- alpha-1 blocker ***
a 49 year old female is treated with unfractionated heparin post
MI. The patient has developed several episodes of epistaxis, and
NR 567 FINAL EXAM LATEST 2025/2026 ACTUAL EXAM WITH
COMPLETE QUESTIONS AND CORRECT DETAILED ANSWERS (100%
VERIFIED ANSWERS) |ALREADY GRADED A+| ||PROFESSOR
VERIFIED|| ||BRANDNEW!!!||
your patient presents with essential hypertension, and in
reviewing lab results, you note that the circulating plasma renin
and catecholamine levels are high. you decide to lower blood
pressure by reducing both cardiac output and systemic vascular
resistance (blocking both alpha and beta-adrenergic receptors)
with a single pharmaceutical agent. which of the following is most
likely to achieve this goal? - ANSWER-labetalol (trandate)
a nonselective beta-blocker was initiated for your patient. which of
the following diagnoses warrants initiating this pharmaceutical
agent? - ANSWER-- asthma
- bradycardia
- severe left ventricular HF
- hyperthyroid crisis ****
you are managing a patient with a history of coronary artery
disease and transient ischemic attacks. low-dose aspirin
,2|Page
treatment is considered, but the patient has a reported history of
aspirin allergy. which of the following is the best alternative? -
ANSWER-- dipyridamole (persantine)
- clopidogrel (plavix) ****
- acetaminophen (tylenol)
- ketorolac (toradol)
which of the following adverse effects is likely when an
angiotensin-converting enzyme inhibitor (ACEI) is used with
spironolactone therapy? - ANSWER-hypotension
hyperkalemia ***
renal insufficiency
proteinuria
all of the following are beneficial effects of beta-blocker therapy
for use in patients with cirrhosis except ________. - ANSWER--
diminished portal hypertension
- increased CO ****
- decreased incidence of esophageal bleeding
-decreased mortality rate
, 3|Page
reducing cardiovascular events in patients with moderate to
severe uncomplicated hypertension is an important consideration
when choosing initial therapy. Which of the following is not
recommended as a first-line treatment to reduce cardiovascular
events? - ANSWER-- angiotensin-converting enzyme inhibitors
(ACEI)
- angiotensin receptor blockers (ARBS)
- beta agonist receptor blockers ****
- dihydropyridine calcium channel blockers (CCB)
which medication class would be most advantageous to use in
treating a patient with hypertension and symptomatic benign
prostatic hyperplasia (BPH) - ANSWER-- thiazide diuretic
- calcium channel blocker
- angiotensin-converting enzyme inhibitor
- alpha-1 blocker ***
a 49 year old female is treated with unfractionated heparin post
MI. The patient has developed several episodes of epistaxis, and
